HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation

Keyphrases

• Adjuvant Arthritis 66%
• Antigen-presenting Cells 33%
• Antigen-specific T Cells 100%
• Arthritogenic 33%
• Autoimmune Disease Model 33%
• Cell Function 33%
• Cell Membrane 33%
• Cytokine Secretion 33%
• Disease-associated 33%
• Fusion Peptide 100%
• Gp41 66%
• HIV Infection 33%
• HIV-1 Fusion Peptide 100%
• Host Cell 33%
• IFN Response 33%
• Immune Response 33%
• Inflammatory Cytokines 33%
• Ionomycin 33%
• Membrane Fusion 33%
• N-terminus 33%
• Peptide Molecules 33%
• Specific T Cells 33%
• T Cell Activation 100%
• T Cell Proliferation 33%
• T Cell Response 33%
• T Cells 33%
• Viral Glycoprotein 33%
• Virion 33%

Immunology and Microbiology

• Amino Terminal Sequence 33%
• Antigen Specificity 100%
• Antigen-Presenting Cell 33%
• Arthritis 66%
• Autoimmune Disease 33%
• CD4 33%
• Cell Membrane 33%
• Cytokine Release 33%
• Glycoprotein 33%
• Gp41 66%
• Host Cell 33%
• Human Immunodeficiency Virus 66%
• Human Immunodeficiency Virus 1 100%
• Human Immunodeficiency Virus Infection 33%
• Immune Response 33%
• Membrane Fusion 33%
• Monospecific Antibody 33%
• Proinflammatory Cytokine 33%
• T Cell 66%
• T Cell Activation 100%
• T Cell Proliferation 33%
• T Cell Receptor 100%
• Virion 33%